EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Defense DEF

Pharmacy issues related to the annual defense reauthorization (HR 4909).

Contacted: Federal Trade Commission (FTC); SENATE; Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Labor, Dept of (DOL); Office of Personnel Management (OPM); White House Office; HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); Internal Revenue Service (IRS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA)

Bills named: H.R. 4909 (114th)

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform law, including the health insurer tax (HR 928/ S 183).

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; Health Resources & Services Administration (HRSA); Federal Trade Commission (FTC); Internal Revenue Service (IRS); White House Office; Office of Personnel Management (OPM); Medicare Payment Advisory Commission (MedPAC); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Labor, Dept of (DOL)

Bills named: H.R. 928 (114th)

Health Issues HCR

Regulatory policies related to the health reform law: structure, drug benefits, disclosure. Regulatory implementation of HITECH/accounting of disclosures. Issues regarding making prescription drugs more affordable. Restrictions on specialty tiering.

Contacted: Labor, Dept of (DOL); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Office of Personnel Management (OPM); SENATE; Congressional Budget Office (CBO); Executive Office of the President (EOP); Federal Trade Commission (FTC); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health Resources & Services Administration (HRSA); White House Office

Postal POS

Postal reform proposals, including rate reform, and their impact on 6 day mail delivery.

Contacted: Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); SENATE; Federal Trade Commission (FTC); Centers For Medicare and Medicaid Services (CMS); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Office of Personnel Management (OPM); Congressional Budget Office (CBO); Food & Drug Administration (FDA); Labor, Dept of (DOL); White House Office; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS)

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General Legislative and regulatory issues such as direct negotiation. Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors prompt pay discounts from the definition of average sales prices. Medicare audit and preferred network restrictions. HR 244; HR 793.

Contacted: Congressional Budget Office (CBO); Government Accountability Office (GAO); Labor, Dept of (DOL); Executive Office of the President (EOP); White House Office; Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Internal Revenue Service (IRS); Office of Personnel Management (OPM); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 244 (114th), H.R. 793 (114th)

Pharmacy PHA

Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR, specialty pharmacy tiering restrictions. Regulatory implementation of a pathway for the approval of biosimilars. REMs. 340b program reform. policies placing restrictions on pharmacy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse, including Medicare lock-in programs. General issues dealing with regulating pharmacy drug compounding. HR 1600; S 1190/ HR793.

Contacted: Labor, Dept of (DOL); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Congressional Budget Office (CBO); Internal Revenue Service (IRS); Federal Trade Commission (FTC); White House Office; Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP)

Bills named: H.R. 793 (114th), H.R. 1600 (114th)